Gain Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Gain Therapeutics

09/08/2022 13:01

* Gain Therapeutics Inc  GANX.OQ  reported a quarterly
adjusted
loss of 43 cents​​ per share for the quarter ended in June. The
mean expectation of four analysts for the quarter was for a loss
of 31 cents per share.
    * Revenue rose 6.7% to $95.00 thousand from a year ago;
analysts
expected $27.33 thousand. 
    * Gain Therapeutics Inc's reported EPS for the quarter was a
loss
of 43 cents​.
    * The mean earnings estimate of analysts had risen by
about 23.6%
in the last three months.​ 
    * In the last 30 days there have been no negative revisions
of
earnings estimates 
    * Gain Therapeutics Inc shares had risen by 16.9% this
quarter and
lost 22.5% so far this year.
    * The company reported a quarterly loss of $5.09 million.
    * Wall Street's median 12-month price target for Gain
Therapeutics
Inc is $21.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data August 9
at 12:01 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2022      -0.31          -0.43          Missed
 Mar. 31 2022      -0.37          -0.28          Beat
 Dec. 31 2021      -0.49          -0.32          Beat
 Sep. 30 2021      -0.36          -0.39          Missed